XML 20 R9.htm IDEA: XBRL DOCUMENT v3.24.3
INVESTMENTS AND FAIR VALUE MEASUREMENTS
4 Months Ended
Apr. 30, 2024
INVESTMENTS AND FAIR VALUE MEASUREMENTS  
INVESTMENTS AND FAIR VALUE MEASUREMENTS

3.  INVESTMENTS AND FAIR VALUE MEASUREMENTS

Marketable Securities

We invest surplus funds in excess of operational requirements in a diversified portfolio of marketable securities, with the objectives of delivering competitive returns, maintaining a high degree of liquidity, and seeking to avoid the permanent impairment of principal.


Investments - current were as follows (in thousands):

 

 


April 30, 2024


 


December 31, 2023


Marketable equity securities

$

50,496


 

$

  62,978


U.S. treasury securities


42,352


 


  41,313


Investments - current

$

 92,848


 

$

   104,291



Investments- noncurrent were as follows (in thousands):

 

 


April 30, 2024


 


December 31, 2023


U.S. treasury securities

$

      19,747


 

$

      13,653


Corporate bonds


  26,798


 


    19,697


Investments - noncurrent

$

 46,545


 

$

   33,350



Marketable securities as of April 30, 2024 and December 31, 2023 consisted of the following (in thousands):

 



April 30, 2024




Cost or Amortized Cost
 
Unrealized Gains
 
Unrealized Losses
 
Fair Value

Marketable equity securities
















Equity securities

$

50,645



$

5,656



$

(5,805

)


$

50,496


Marketable debt securities
















U.S. treasury securities


61,306




825




(32

)



62,099


Corporate bonds


25,695




1,151




(48

)



26,798


Total marketable debt securities


87,001




 1,976




(80

)



 88,897



$

137,646



$

7,632



$

(5,885

)


$

139,393


 



December 31, 2023




Cost or Amortized Cost




Unrealized Gains




Unrealized Losses




Fair Value


Marketable equity securities
















Equity securities

$

 59,228



$

7,896



$

(4,146

)


$

62,978


Marketable debt securities
















U.S. treasury securities


53,662




1,307




(3

)



54,966


Corporate bonds


19,422




472




(197

)



19,697


Total marketable debt securities


 73,084




1,779




(200

)



74,663



$

132,312



$

 9,675



$

(4,346

)


$

 137,641


 

The amortized costs and fair value of our marketable debt securities, by contractual maturity, as of April 30, 2024 (in thousands) are as follows: 

 



April 30, 2024




Amortized Cost




Fair Value


Less than 1 year

$

 41,522



$

42,352


1 to 5 years


45,479




46,545


Total

$

 87,001



$

88,897


       As of April 30, 2024, the fair value of corporate bonds with unrealized loss position was $5.6 million, with an aggregated loss of less than $0.1 million. As of April 30, 2024, the fair value of treasury securities with unrealized loss position was $25.2 million, with an aggregated loss of less than $0.1 millionAs of December 31, 2023, the fair value of available-for-sale debt securities in unrealized loss position for corporate bonds and U.S. treasury securities were $7.1 million and $2.7 million, respectively, with an aggregated loss of $0.2 million. For all available-for-sale debt securities that were in unrealized loss positions, we have determined that it is more likely than not we will hold the securities until maturity or a recovery of the cost basis. We had no credit-related impairment loss as of April 30, 2024 and December 31, 2023.


Derivative Financial Instruments

 

Our derivative instruments consisted of call and put options valued at their fair value as of the balance sheet date. These derivative instruments are reported as Other current liabilities on our Condensed Consolidated Balance Sheets as of April 30, 2024 and December 31, 2023 (in thousands):

 



April 30, 2024




Cost




Unrealized Losses




Fair Value


Derivative instruments

$

7,935



$

(2,495

)


$

5,440



$

7,935



$

(2,495

)


$

5,440


 



December 31, 2023




Cost




Unrealized Losses




Fair Value


Derivative instruments

$

8,797



$

(867

)


$

7,930



$

8,797



$

(867

)


$

7,930



A summary of realized and unrealized gains and losses from our equity securities and derivative instruments and realized losses from our marketable debt securities are as follows (in thousands):

 



Four Months Ended April 30, 2024




Three Months Ended March 31, 2023


Net unrealized gains (losses) recognized on marketable equity securities

$

(3,899

)


$

2,014

Net realized gains recognized on marketable equity securities


 6,778



1,669

Net unrealized gains (losses) recognized on derivative instruments


468



(102

)

Net realized gains recognized on derivative instruments


1,627



717


Net realized gains recognized on marketable debt securities


338




Total net gains recognized in interest and other income, net

$

 5,312


$

4,298


Fair Value Measurements

Our financial instruments include cash and cash equivalents, receivables, accounts payable and accrued liabilities. The fair value of cash and cash equivalents, receivables, accounts payable and accrued liabilities approximates their carrying values because of the short-term nature of these instruments, which are all considered Level 1.

Our financial instruments measured at fair value on a recurring basis consisted of equity securities, corporate bonds, U.S. treasury securities and derivatives.  U.S. treasury securities and equity securities are classified within Level 1 of the fair value hierarchy as they are valued based on quoted market price in an active market. Corporate bonds and derivative instruments are valued based on quoted prices in markets that are less active, broker or dealer quotations, or alternative pricing sources that are observable or can be corroborated by observable market data are generally classified within Level 2 of the fair value hierarchy.

 

Financial instruments valued based on unobservable inputs which reflect the reporting entity’s own assumptions or data that market participants would use in valuing an instrument are generally classified within Level 3 of the fair value hierarchy. We did not hold Level 3 financial instruments as of April 30, 2024, and December 31, 2023.


Financial instruments measured at fair value on a recurring basis as of April 30, 2024 and December 31, 2023 are classified based on the valuation technique in the table below (in thousands):

 



April 30, 2024








Fair Value Measurements Using








Quoted Prices in Active Markets for Identical Assets (Level 1)




Significant Other Observable Inputs (Level 2)




Significant Unobservable Inputs (Level 3)




Total


Assets:
















U.S. treasury securities 

$

 —



$

 62,099



$

 —



$

62,099


Equity securities


50,496




 —







 50,496


Corporate bonds


 8,220




 18,578







 26,798


Total assets at fair value

$

58,716



$

 80,677



$



$

139,393


















Liabilities
















Derivative instruments

$

 —



$

 5,440



$



$

5,440


Total liabilities at fair value

$

 —



$

 5,440



$



$

5,440


 



December 31, 2023








Fair Value Measurements Using








Quoted Prices in Active Markets for Identical Assets (Level 1)




Significant Other Observable Inputs (Level 2)




Significant Unobservable Inputs (Level 3)




Total


Assets:
















U.S. treasury securities

$

54,966



$

  —



$


$

54,966


Equity securities


 62,977







 —




 62,977


Corporate bonds





19,697




  —




19,697


Total assets at fair value

$

117,943



$

19,697



$



$

137,640


















Liabilities
















Derivative instruments

$

 —



$

 7,930



$

  —



$

  7,930


Total liabilities at fair value

$

 —



$

  7,930



$

 —



$

7,930